Investors purchased shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) on weakness during trading hours on Monday. $148.40 million flowed into the stock on the tick-up and $30.71 million flowed out of the stock on the tick-down, for a money net flow of $117.69 million into the stock. Of all equities tracked, iShares Nasdaq Biotechnology ETF had the 3rd highest net in-flow for the day. iShares Nasdaq Biotechnology ETF traded down ($1.56) for the day and closed at $116.21

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. SP Asset Management bought a new stake in shares of iShares Nasdaq Biotechnology ETF during the 2nd quarter worth $2,721,000. Schroder Investment Management Group bought a new stake in shares of iShares Nasdaq Biotechnology ETF during the 2nd quarter worth $105,000. Private Management Group Inc. raised its stake in shares of iShares Nasdaq Biotechnology ETF by 7.4% during the 2nd quarter. Private Management Group Inc. now owns 90,010 shares of the financial services provider’s stock worth $9,885,000 after purchasing an additional 6,184 shares during the period. Martin & Co. Inc. TN raised its stake in shares of iShares Nasdaq Biotechnology ETF by 9.6% during the 2nd quarter. Martin & Co. Inc. TN now owns 35,863 shares of the financial services provider’s stock worth $3,938,000 after purchasing an additional 3,130 shares during the period. Finally, HPM Partners LLC raised its stake in shares of iShares Nasdaq Biotechnology ETF by 4.1% during the 2nd quarter. HPM Partners LLC now owns 23,074 shares of the financial services provider’s stock worth $2,534,000 after purchasing an additional 900 shares during the period. Institutional investors own 64.16% of the company’s stock.

iShares Nasdaq Biotechnology ETF Company Profile (NASDAQ:IBB)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Article: Asset Allocation Models, Which is Right For You?

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.